IP Library Granted Patent US 9,393,205
Granted Patent B2
US 9,393,205 · App. 14/374,568 · Granted Jul 19, 2016

Gastroretentive tablets

Inventors: Varinder Kumar (Mohali, IN); Shavej Ahmad (Lucknow, IN); Romi Barat Singh (Varanasi, IN)
Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
A61K9/2054A61K9/0065A61K9/205A61K9/2009A61K9/2013A61K9/2018A61K9/2027A61K9/2031A61K9/2095A61K31/197
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,393,205
App. No.
14/374,568
Granted
Jul 19, 2016
Kind
B2
Abstract

The present invention relates to a gastroretentive tablet comprising pregabalin, at least one swellable polymer, and other pharmaceutically acceptable excipients. It further relates to a process for the preparation of same.

Claims (10)

1. A gastroretentive tablet comprising pregabalin, at least one swellable polymer, and other pharmaceutically acceptable excipients.

2. The gastroretentive tablet according to claim 1 , wherein the tablet further comprises a gas generating agent.

3. The gastroretentive tablet according to claim 1 , wherein the other pharmaceutically acceptable excipients are selected from diluents, binders, disintegrants, glidants, lubricants, and coloring agents.

4. The gastroretentive tablet according to claim 1 , wherein the swellable polymer is selected from cellulose polymers, gums, polyethylene oxide, carbomer, superdisintegrant polymers, and combinations thereof.

5. The gastroretentive tablets according to claim 2 , wherein the gas generating agent is selected from carbonates, bicarbonates, sufites, and mixtures thereof.

6. The gastroretentive tablet according to claim 5 , wherein the gas generating agent additionally comprises an acid source.

7. The gastroretentive tablet according to claim 1 , wherein the tablet additionally comprises a matrix forming agent.

8. The gastroretentive tablet according to claim 7 , wherein the matrix forming agent is a formulated mixture of polyvinyl acetate and polyvinylpyrrolidone.

9. A process for the preparation of a gastroretentive tablet comprising pregabalin, at least one swellable polymer, and other pharmaceutically acceptable excipients selected from diluents, binders, disintegrants, glidants, lubricants, and coloring agents, wherein the process comprises the conventional methods of dry granulation, wet granulation, and direct compression.

10. The process according to claim 9 , wherein the process includes using a gas generating agent.

Assignments (2)
MERGER Recorded Jan 13, 2016
From: RANBAXY LABORATORIES LIMTED
To: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Reel/Frame 037513/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2014
From: KUMAR, VARINDER; AHMAD, SHAVEJ; SINGH, ROMI BARAT
To: RANBAXY LABORATORIES LIMITED
Reel/Frame 033423/0405 →
Priority Claims (2)
IN 250/DEL/2012 · Jan 30, 2012 · national
IN 252/DEL/2012 · Jan 30, 2012 · national
Continuity (1)
Related Publication 20150025146A1 · Jan 22, 2015